Areas with benign morphologic and immunohistochemical features are associated with some uterine leiomyosarcomas

Gynecologic Oncology

Volumn 104, Issue 2, 2007, Pages 362-365

  Mittal, Khush ^a   Joutovsky, Alla ^a  

^a BELLEVUE HOSPITAL CENTER   (United States)

Author keywords

Leiomyoma; Leiomyosarcomas; Uterus

Indexed keywords

KI 67 ANTIGEN; MONOCLONAL ANTIBODY; PROTEIN P53;

ARTICLE; CELL COUNT; CELL DEATH; CLINICAL ARTICLE; EVALUATION; HUMAN; HUMAN TISSUE; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; MITOSIS; MORPHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; UTERINE LIEOMYOSARCOMA; UTERUS SARCOMA;

FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LEIOMYOSARCOMA; PRECANCEROUS CONDITIONS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; UTERINE NEOPLASMS;

EID: 33846387910     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.08.034     Document Type: Article

References (13)

1. Leibsohn S., d'Ablaing G., Mischell Jr. D.R., and Schaerth J.B. Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas. Am. J. Obstet. Gynecol. 162 (1990) 968-974
2. Parker W.H., Fu Y.S., and Berek J.S. Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma. Obstet. Gynecol. 83 (1994) 414-418
3. Kir G., Eren S., Akoz I., and Kir M. Leiomyosarcoma of the broad ligament arising in a pre-existing pure neurilemmoma-like leiomyoma. Eur. J. Gynaecol. Oncol. 24 (2003) 505-506
4. Scurry J., and Hack M. Leiomyosarcoma arising in a lipoleiomyoma. Gynecol. Oncol. 39 (1990) 381-383
5. Mittal K., Popiolek D., and Demopoulos R.I. Uterine Myxoid leiomyosarcoma within a leiomyoma. Human Pathol. 31 (2000) 398-400
6. Jatoi N. Leiomyosarcoma: rare malignant change in a leiomyoma. J. Coll. Phys. Surg. (Pakistan) 13 (2003) 106-107
7. Herbold D.R., Fu Y.S., and Silbert S.W. Leiomyoma of the broad ligament. A case report and literature review with follow-up. Am. J. Surg. Pathol. 7 (1983) 285-292
8. Mittal K., and Demopoulos R.I. MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors. Human Pathol. 32 (2001) 984-987
9. Levy B., Mukherjee T., and Hirschhorn K. Molecular cytogenetic analysis of uterine leiomyoma and leiomyosarcoma by comparative genomic hybridization. Cancer Genet. Cytogenet. 121 (2000) 1-8
10. Moore S.D., Herrick S.R., Ince T.A., Kleinman M.S., Cin P.D., Morton C.C., et al. Uterine leiomyomata with t(10;17) disrupt the histone acetyltransferase MORF. Cancer Res. 15 (2004) 5570-5577
11. Iliszko M., Mandahl N., Mrozek K., Denis A., Pandis N., Pejovic T., et al. Cytogenetics of uterine sarcomas: presentation of eight new cases and review of the literature. Gynecol. Oncol. 71 (1998) 172-176
12. Ozisik Y.Y., Meloni A.M., Surti U., and Sandberg A.A. Involvement of 10q22 in leiomyoma. Cancer Genet. Cytogenet. 69 (1993) 132-135
13. Christacos N.C., Quade BradleyJ., Dal Cin P., and Morton C.C. Leiomyomata with deletions of 1p represent a distinct cytogenetic subgroup associated with unusual histologic features. Genes Chromosomes Cancer 45 (2006) 304-312